tirzepatide shortage reddit New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our Trends in Glucagon-Like Peptide-1 Receptor

Theyre also being evaluated for many other conditions, including breast cancer

Zhao G, Wang X

These findings offer potential biomarkers and therapeutic targets for clinical management

Delayed gastric emptying on GLP-1 therapy can cause burping and stomach-derived mouth odor, and clinicians often log three things over one week to link burps or reflux to injection timing

In keeping with this observation, here we unveil a crucial role of GSH in lipid production, as the synthesis of GSH, specifically in the liver, is required for sustaining physiological circulating triglyceride levels (an important energy source) and adipose tissue homeostasis under standard dietary regimen